The somatostatin-gastrin link of Helicobacter pylori infection
- PMID: 8541034
- DOI: 10.3109/07853899509002471
The somatostatin-gastrin link of Helicobacter pylori infection
Abstract
Helicobacter pylori is the new-found cause of duodenal ulcers (DU), but acid secretion remains necessary and is elevated in DU patients. My group and others have asked whether H. pylori itself alters gastric physiology. This infection has been found to decrease local expression of the inhibitory peptide somatostatin, and to increase release of the acid-stimulating hormone gastrin. H. pylori infection can alter acid secretion in both directions. Acid disappears temporarily on first infection, and may dwindle later if H. pylori causes gastric atrophy. DU patients have approximately twice the normal parietal cell mass, which increases their maximal secretory capacity, but it is not clear whether or not this is due to H. pylori. However, the infection certainly does change physiological control of acid secretion, as expected from the endocrine changes. Acid secretion is elevated during fasting, during stimulation with an acidic meal and during infusions of gastrin-releasing peptide. The balance between these opposing effects of H. pylori on acid may be crucial in determining the clinical outcome of H. pylori infection. High-acid secretion leads to DUs whilst low acid secretion is found in patients with gastric ulcers and gastric cancer. Inflammatory cytokines released in H. pylori gastritis may cause some of these changes in gastric physiology.
Similar articles
-
Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.J Physiol Pharmacol. 1994 Dec;45(4 Suppl 1):3-66. J Physiol Pharmacol. 1994. PMID: 7787215 Review.
-
Eradication of Helicobacter pylori restores the inhibitory effect of cholecystokinin on postprandial gastrin release in duodenal ulcer patients.Gut. 1995 Oct;37(4):482-7. doi: 10.1136/gut.37.4.482. Gut. 1995. PMID: 7489932 Free PMC article.
-
Helicobacter pylori and gut hormones.J Gastroenterol. 2002;37(2):77-86. doi: 10.1007/s005350200000. J Gastroenterol. 2002. PMID: 11871770 Review.
-
Eradication of Helicobacter pylori and gastrin-somatostatin link in duodenal ulcer patients.J Physiol Pharmacol. 1996 Mar;47(1):161-75. J Physiol Pharmacol. 1996. PMID: 8777296 Clinical Trial.
-
Helicobacter pylori infection, serum gastrin, and gastric acid secretion in teen-age subjects with duodenal ulcer, gastritis, or normal mucosa.Scand J Gastroenterol. 1995 Apr;30(4):322-6. doi: 10.3109/00365529509093284. Scand J Gastroenterol. 1995. PMID: 7610346
Cited by
-
Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma.Cancer Lett. 2011 Jun 28;305(2):228-38. doi: 10.1016/j.canlet.2010.07.014. Epub 2010 Aug 7. Cancer Lett. 2011. PMID: 20692762 Free PMC article. Review.
-
Suppressed Gastric Mucosal TGF-beta1 Increases Susceptibility to H. pylori-Induced Gastric Inflammation and Ulceration: A Stupid Host Defense Response.Gut Liver. 2010 Mar;4(1):43-53. doi: 10.5009/gnl.2010.4.1.43. Epub 2010 Mar 25. Gut Liver. 2010. PMID: 20479912 Free PMC article.
-
Pathobiology of Helicobacter pylori infection.Yale J Biol Med. 1998 Mar-Apr;71(2):43-51. Yale J Biol Med. 1998. PMID: 10378349 Free PMC article. Review. No abstract available.
-
Pathogenicity of Helicobacter pylori in cancer development and impacts of vaccination.Gastric Cancer. 2019 Jan;22(1):23-36. doi: 10.1007/s10120-018-0867-1. Epub 2018 Aug 25. Gastric Cancer. 2019. PMID: 30145749 Review.
-
Serum ghrelin and esophageal and gastric cancer in two cohorts in China.Int J Cancer. 2020 May 15;146(10):2728-2735. doi: 10.1002/ijc.32597. Epub 2019 Aug 12. Int J Cancer. 2020. PMID: 31351006 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical